Fig. 1From: Antibody-based proteomics to identify an apoptosis signature for early recurrence of hepatocellular carcinomaSurvival curves of the 40 patients with HCC included in this study. Overall survival is shown for the two groups of patients: group S did and group L did not have recurrence within 2 years of surgery (n = 20 each). The two groups presented distinct prognosesBack to article page